M.RO Med Life SA

Healthcare Medical Care Facilities Bucharest Stock Exchange
11.00 RON
Close of Oct 29, 2026
8.20 14.28
Market cap
RON 5.70B
P/E
1,100.0x
P/B
12.38x
ROE
-12.2%
Dividend yield
-
Fundamental score
1.3/5

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is M.RO undervalued?

Graham number

The Graham number of Med Life SA cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Med Life SA fundamental analysis

4 of 21 checks passed

ROE 0/2

Low return on equity (-12.2%), below 10%.

ROA 0/1

Return on assets (-1.7%) is below the industry median (2.5%).

Profit Consistency 2/2

Profitable for 5 consecutive years.

Earnings Growth 5Y 0/1

Earnings per share history is shorter than 5 years.

Earnings Acceleration 0/1

Not enough positive earnings history to compare last year's growth with the 5-year average.

Earnings Growth vs Industry 1/1

Last year's EPS growth (587.1%) is above the industry median (28.6%).

Revenue Growth 2/2

Revenue grew 23.9% a year over the past 3 years.

Short-term Liquidity 0/1

Current assets do not cover short-term liabilities.

Long-term Liabilities 0/1

Current assets do not cover long-term liabilities.

Debt to Equity 0/2

High debt to equity (328.5%), above 100%.

Debt Trend 0/1

Debt to equity history is shorter than 5 years.

Cash Runway 2/2

Loss-making but free cash flow is positive.

PE vs Market 0/1

PE (1,074.0x) is above the market median (18.3x).

PE vs Industry 0/1

PE (1,074.0x) is above the industry median (27.5x).

PBV 0/1

Price to book (12.1x) is above the industry median (5.0x).

Graham Number 0/1

The price is above the Graham number (PE x PB = 12,982.6, limit 22.5).

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 0/2

No dividend paid in the last reported year.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 0/1

No dividend, or no profit to pay it from.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Med Life SA stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Med Life SA

Med Life S.A., a private healthcare provider, provides integrated medical services through its clinics and hospitals in Romania. The company offers outpatient units and diagnostic imaging services; consultations with general practitioners and specialists; diagnostic imaging tests; day hospitalization services; hospitalization and surgical treatment services; medical and surgical specialties; maternal and child health dedicated services; and stem cell bank. It also provides l…

Full company profile